Axla stock forecast.

Find real-time CYBN - Cybin Inc stock quotes, company profile, news and forecasts from CNN Business.US05454B2043. Axcella Health, Inc. is a biotechnology company. It engages in the research and development of treatment for diseases and improves health using endogenous metabolic modulator, or EMM, and compositions. Its product pipeline includes AXA1665, for the reduction in risk of recurrent overt hepatic encephalopathy, and AXA1125, for non ...The reverse stock split will become effective at 5:00 p.m. Eastern Time on September 18, 2023, after close of trading on The Nasdaq Global Market. The Company’s common stock is expected to ...Stock Price Forecast The 5 analysts offering 12-month price forecasts for Canoo Inc have a median target of 1.50, with a high estimate of 3.00 and a low estimate of 0.30. Stock Price Forecast. The 23 analysts offering 12-month price forecasts for Procter & Gamble Co have a median target of 169.00, with a high estimate of 177.00 and a low estimate of 139.00. The ...Web

13 brokerages have issued twelve-month price targets for Royal Bank of Canada's stock. Their RY share price targets range from C$122.00 to C$142.00. On average, they predict the company's share price to reach C$133.21 in the next twelve months. This suggests a possible upside of 8.4% from the stock's current price.WebAXLA : 0.4300 (+0.02%) Axcella Health Inc. (AXLA) Loses 47.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Zacks - Fri Nov 11, 2022. Axcella Health …

Forecst.com predicts future values using technical analysis of a large number of analytical parameters. AXLA stock returns are also predicted based on historical data. According to our research, AXLA stock is a bad long-term investment. AXLA share price has been in a bear cycle for the past year. Axcella Health Inc. stock trend is negative .Aug 29, 2023 · CAMBRIDGE, Mass., August 29, 2023--Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company focused on pioneering a new approach to address the biology of complex diseases using ...

How much is Axcella Health stock worth today? ( NASDAQ: AXLA) Axcella Health currently has 2,947,710 outstanding shares. With Axcella Health stock trading at $5.43 per share, the total value of Axcella Health stock (market capitalization) is $16.01M. Axcella Health stock was originally listed at a price of $345.00 in May 9, 2019.We use our expertise to forecast stock prices. [email protected]; Market Opinions. Any opinions, news, research, analyses, prices, or other information offered by AIStockFinder is provided as general market commentary, and does not constitute investment advice. AIStockFinder will not accept liability for any loss or …Axcella Health Inc (AXLA) Company Description. Axcella Health Inc a biotechnology company focused on treating complex diseases and improve health using endogenous metabolic modulator, or EMM, compositions. Its product candidates are comprised of multiple EMMs that are engineered in distinct combinations and ratios to simultaneously impact ... Nov 27, 2023 · Broker Rating. Only one brokerage firm provided a Hold-equivalent recommendation for Axcella Health Inc. This translates to an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 ...

CYBN Stock 12 Months Forecast. $5.50. (1067.48% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cybin in the last 3 months. The average price target is $5.50 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 1067.48% change from the last price of $0.47.

AXLA is currently covered by 1 analysts with an average potential upside of $-15.83 (90.19%) backed by displayed 0 price targets and 5 ratings. Stock Analyst Price Targets - Review Analysts average stock forecasts to be materialized ratio is 76.67% with an average time for these price targets to be met of 570.2 days.

According to the issued ratings of 2 analysts in the last year, the consensus rating for Axcella Health stock is Hold based on the current 2 hold ratings for AXLA. The average twelve-month price prediction for Axcella Health is $50.00 with a high price target of $50.00 and a low price target of $50.00. Learn more on AXLA's analyst rating history.Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.Web19 equities research analysts have issued 12-month price targets for Albemarle's stock. Their ALB share price targets range from $140.00 to $403.00. On average, they expect the company's share price to reach $232.37 in the next year. This suggests a possible upside of 84.2% from the stock's current price.Axcella Health started at buy with $14 stock price target at B. Riley FBR Sep. 25, 2020 at 7:34 a.m. ET by Tomi Kilgore Axcella Health started at outperform with $28 stock price …Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...Their ONCT share price targets range from $1.30 to $9.00. On average, they predict the company's share price to reach $4.10 in the next year. This suggests a possible upside of 1,161.5% from the stock's current price. View analysts price targets for ONCT or view top-rated stocks among Wall Street analysts.Web

To put that in perspective, shares of AXLA stock closed out Thursday at a price of $1.01 cents. Falling below that minimum bid price for too long would see the shares delisted from the exchange.Great news for Axcella Health Inc. (NASDAQ:AXLA): Insiders acquired stock in large numbers last year (Simply Wall St.) Jun-27-22 02:35PM From Axcella To Tonix, Here Are The Penny Stocks Of Companies Working On Long Covid (Investor's Business Daily) May-27 …Nov 24, 2023 · 8 Wall Street research analysts have issued 1-year target prices for Kura Oncology's shares. Their KURA share price targets range from $10.50 to $37.00. On average, they predict the company's share price to reach $27.31 in the next twelve months. This suggests a possible upside of 185.7% from the stock's current price. Find the latest Outlook Therapeutics, Inc. (OTLK) stock quote, history, news and other vital information to help you with your stock trading and investing.WebAccording to our price prediction algorithm,Axcella Health Inc. (AXLA) price will be around $0.17 in the next 2 weeks. This means it will increase by 0.8% from the last closing price. …ZIM Integrated Shipping Services (NYSE:ZIM) pays an annual dividend of $9.35 per share and currently has a dividend yield of 134.73%. ZIM has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for ZIM.Web

Short Borrow Fee Rates. AXLA / Axcella Health Inc short borrow fee rates are shown in the following table. This table shows the interest rate that must be paid by a short seller of US:AXLA to the lender of that security. This fee is shown as …Amazon.com Inc EBIT Forecast for 2023 - 2025 - 2030. In the last three years, Amazon.com Inc's EBIT has decreased from $14.54B to $12.25B – a 15.77% drop! For the next year, analysts are expecting EBIT to reach $46.04B – an increase of 275.91%. Over the next eight years, experts predict that EBIT will grow by 2070.64%.

Tesla Stock Forecast 2023, 2024, 2025. Apple stock predictions for January 2025. The forecast for beginning of January 275. Maximum value 293, while minimum 259. Averaged Apple stock price for month 276. Price at the end 276, change for January 0.36%. Apple stock price predictions for February 2025.WebManila Stock Market & Finance report, prediction for the future: You'll find the AC Energy Philippines share forecasts, stock quote and buy / sell signals below. According to present data AC Energy Philippines's ACEN shares and potentially its market environment have been in bearish cycle last 12 months (if exists).WebDec 1, 2023 · The SCWorx Corp. stock price fell by -6.47% on the last day (Friday, 17th Nov 2023) from $1.87 to $1.75. During the last trading day the stock fluctuated 7.65% from a day low at $1.72 to a day high of $1.85. The price has been going up and down for this period, and there has been a -8.85% loss for the last 2 weeks. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Knightscope Inc - Class A share forecasts, stock quote and buy / sell signals below. According to present data Knightscope Inc - Class A's KSCP shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Axcella Health Inc (AXLA) Company Description. Axcella Health Inc a biotechnology company focused on treating complex diseases and improve health using endogenous metabolic modulator, or EMM, compositions. Its product candidates are comprised of multiple EMMs that are engineered in distinct combinations and ratios to simultaneously impact ...This translates to an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell). ABR is the calculated average of actual …Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Energous Corp have a median target of 3.50, with a high estimate of 3.50 and a low estimate of 3.50. The median estimate ...Nov 28, 2023 · Forecst.com predicts future values using technical analysis of a large number of analytical parameters. AXLA stock returns are also predicted based on historical data. According to our research, AXLA stock is a bad long-term investment. AXLA share price has been in a bear cycle for the past year. Axcella Health Inc. stock trend is negative . AXLA stock closed at $15.00 and is down -$0.96 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. AXLA has a roughly average overall score of 37 meaning the stock holds a better value than 37% of stocks at its current price.

Nov 30, 2023 · AXLA's stock price has decreased by -95.38% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 1 stock analyst, the 12-month stock price forecast for Axcella Health stock is $50, which predicts an increase of 4,976.14%.

Nov 30, 2023 · AXLA's stock price has decreased by -95.38% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 1 stock analyst, the 12-month stock price forecast for Axcella Health stock is $50, which predicts an increase of 4,976.14%.

Axcella Health Stock Chart and Share Price Forecast, Short-Term "AXLA" Stock Prediction for Next Days and Weeks Walletinvestor.com Axcella Health Inc (AXLA) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024 1 M 3 M YTD 1 Y 3 Y $ % Advanced Charting Compare Compare to Benchmark: DJIA S&P 500 GLOBAL DOW NASDAQ Health Care/Life Sciences Compare to Open 0.999 Prior …We forecast stock performance using neural networks based on historical data. In our forecasting, we also use technical analysis tools and consider global geopolitical factors and news events. But remember that all forecast data on the site is provided for informational purposes for the use of neural forecasting tools in the …Oct 15, 2020 · Axcella Health (AXLA) stock price prediction is 2.4690304710724 USD. The Axcella Health stock forecast is 2.4690304710724 USD for 2024 November 23, Saturday with technical analysis. Axcella Health IPO would value co. at up to $505.7 mln. Apr. 30, 2019 at 10:29 a.m. ET by Tomi Kilgore.We use our expertise to forecast stock prices. [email protected]; Market Opinions. Any opinions, news, research, analyses, prices, or other information offered by AIStockFinder is provided as general market commentary, and does not constitute investment advice. AIStockFinder will not accept liability for any loss or …Axcella Health Stock Chart and Share Price Forecast, Short-Term "AXLA" Stock Prediction for Next Days and Weeks Walletinvestor.com Axcella Health Inc (AXLA) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024US05454B2043. Axcella Health, Inc. is a biotechnology company. It engages in the research and development of treatment for diseases and improves health using endogenous metabolic modulator, or EMM, and compositions. Its product pipeline includes AXA1665, for the reduction in risk of recurrent overt hepatic encephalopathy, and AXA1125, for non ...Dec 3, 2023 · Nov. 02. MT. Wedbush Adjusts Axcella Health's Price Target to $6 From $9, Citing Stock Dilution; Outperform Rating Kept. 2022. MT. HC Wainwright Adjusts Axcella Health's Price Target to $10 From $8, Maintains Buy Rating. 2022. MT. More recommendations. SCHD Signals & Forecast. Mostly positive signals in the chart today. The SCHWAB U.S. DIVIDEND EQUITY SCHWAB U.S. ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term …WebStock prices may also move more quickly in this environment. Investors who anticipate trading during these times are strongly advised to use limit orders. Real-time Data is …When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.

The Apache stock price fell by -0.192% on the last day (Wednesday, 29th Nov 2023) from $36.38 to $36.31. During the last trading day the stock fluctuated 1.66% from a day low at $36.19 to a day high of $36.79. The price has fallen in 6 of the last 10 days and is down by -3.35% for this period. Volume fell on the last day along with the stock ...WebThe GLOBAL X LITHIUM GLOBAL X LITHIUM ETF price fell by -1.29% on the last day (Wednesday, 22nd Nov 2023) from $49.44 to $48.80. During the last trading day the ETF fluctuated 1.65% from a day low at $48.51 to a day high of $49.31. The price has been going up and down for this period, and there has been a 0.51% gain for the last 2 …Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Find real-time NVDA - NVIDIA Corp stock quotes, company profile, news and forecasts from CNN Business.Instagram:https://instagram. teladoc stocksyield on 6 month treasury billsfoi stockwhich 1943 steel penny is valuable Dec 1, 2023 · The Energous Corporation stock price gained 6.63% on the last trading day (Wednesday, 22nd Nov 2023), rising from $1.96 to $2.09. During the last trading day the stock fluctuated 18.09% from a day low at $1.88 to a day high of $2.22. The price has fallen in 6 of the last 10 days and is down by -18.2% for this period. 2020 lambo1979 liberty dollar1 coin Price target increased to US$15.71. In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Axcella Health has not provided enough past data and has no analyst forecast, its future earnings ...AXLA : 0.4300 (+0.02%) Axcella Health Inc. (AXLA) Loses 47.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Zacks - Fri Nov 11, 2022. Axcella Health … space etf This translates to an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell). ABR is the calculated average of actual …Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company focused on pioneering a new approach to address the biology of complex diseases using compositions of endogenous metabolic modulators (EMMs), today announced that its Board of Directors has approved a 1-for-25 reverse stock split of the Company’s common stock.Dec 1, 2023 · It is engaged in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism. The company's principal candidate consists of AXA1665 ...